Image

Alexandra Wyles

Counsel

Email

alexandra.wyles@aoshearman.com

Phone

+44 20 3088 2639

Offices

London

V-CARD
Alexandra advises on a wide range of commercial matters, with a particular focus on IP and technology-rich sectors such as life sciences/healthcare, consumer/retail and TMT.
Alexandra regularly advises on complex commercial arrangements in these sectors including collaboration agreements, licensing deals, manufacturing and supply arrangements and distribution agreements. Alexandra also advises on non-contentious intellectual property matters, including IP aspects of M&A and corporate transactions and other arrangements for the exploitation of IP, and information technology and service provision arrangements.

Experience

Representative matters

Life Sciences
  • Reckitt on the proposed sale of its E45 brand and related sub-brands to Karo Pharma for an implied enterprise value of GBP200m.
  • Grünenthal on its USD922m acquisition from AstraZeneca of prescription products Nexium in Europe and Vimovo worldwide (excluding the U.S. and Japan).
  • Grünenthal on the acquisition of the European business of Crestor™ (rosuvastatin) and associated second brands (excluding the UK and Spain) from AstraZeneca.
Consumer/Retail
  • Hanesbrands Inc. on the disposal of its Hanes Europe Innerwear business to Regent LP.
  • Imperial Brands plc on the sale of its worldwide premium cigar business to investment consortia of individual investors in two distinct transactions for a total consideration of €1,225 million (£1,074 million).

Pro bono

  • Mentoring young people through A&O’s award-winning Smart Start programme.
  • Advising a UK schools charity in relation to agreements with certain corporate partners. 

Qualifications

Admissions

Admitted as a Solicitor (England and Wales), 2013

Academic

LPC, College of Law, 2011

LLB, Law, University of Warwick, 2009

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.